Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R9 - Effective November 18, 2024

Date Posted: February 10, 2025

This Billing and Coding Article has been revised under contractor numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: November 18, 2024

Summary of Changes:

Under Article Text revised Table 1 row 11 to add "Guardant Reveal (Guardant, Inc) single Plasma Test". This revision is due to covered test that has successfully completed a TA and is effective for 11/18/2024.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated Feb 10 , 2025